JPH10276796A - Physiological activity measuring method and device therefor - Google Patents
Physiological activity measuring method and device thereforInfo
- Publication number
- JPH10276796A JPH10276796A JP9092639A JP9263997A JPH10276796A JP H10276796 A JPH10276796 A JP H10276796A JP 9092639 A JP9092639 A JP 9092639A JP 9263997 A JP9263997 A JP 9263997A JP H10276796 A JPH10276796 A JP H10276796A
- Authority
- JP
- Japan
- Prior art keywords
- physiological activity
- dissolved oxygen
- measured
- amount
- predetermined time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
(57)【要約】
【課題】 短時間で薬剤感受性などの生理活性を正確に
測定する。
【解決手段】 生理活性測定対象物質を添加した培地
と、生理活性測定対象物質および生理活性測定用試薬を
添加した培地とを準備し、両培地中の溶存酸素量を酸素
電極4を用いて測定し、測定された溶存酸素量を比較す
ることにより生理活性を測定するに当って、酸素電極4
に対して測定のためのバイアス電圧を印加した後、第1
の所定時間が経過してから第2の所定時間が経過するま
での時間範囲内における溶存酸素量の変化割合に基づい
て生理活性を測定する。
(57) [Summary] [Problem] To accurately measure a physiological activity such as drug sensitivity in a short time. SOLUTION: A medium to which a physiological activity measurement target substance is added and a medium to which a physiological activity measurement target substance and a reagent for physiological activity measurement are added are prepared, and the amount of dissolved oxygen in both mediums is measured using an oxygen electrode 4. In measuring the physiological activity by comparing the measured dissolved oxygen amounts, the oxygen electrode 4
After applying a bias voltage for measurement to
The physiological activity is measured based on the change rate of the dissolved oxygen amount within the time range from when the predetermined time elapses to when the second predetermined time elapses.
Description
【0001】[0001]
【発明の属する技術分野】この発明は生理活性測定方法
およびその装置に関し、さらに詳細にいえば、細菌、細
胞などに対する薬剤感受性、BOD(Biologic
al Oxygen Demand)などの環境計測、ア
レルゲン測定、DNA量の測定、血管障害の検出などの
生理活性を測定するための方法およびその装置に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method and apparatus for measuring biological activity, and more particularly, to drug sensitivity to bacteria, cells, etc., and BOD (Biologic).
The present invention relates to a method and an apparatus for measuring a physiological activity such as environmental measurement such as al Oxygen Demand), allergen measurement, DNA amount measurement, and detection of vascular disorder.
【0002】[0002]
【従来の技術】従来から、細菌、細胞などに対する薬剤
感受性を測定するための標準的な方法として、KBディ
スク法が知られている。このKBディスク法は、予め薬
剤を添加してあるろ紙の周囲のどの程度の範囲まで細
菌、細胞の増殖を抑制するかを目視により判定する方法
である。したがって、目視で判定できる程度にまで細
菌、細胞を増殖させることが必要であり、所要時間が著
しく長くなってしまうという不都合がある。特に、抗生
物質の迅速投与、抗がん剤の手術中投与などのように、
薬剤感受性を迅速に測定する必要がある場合には到底対
処することができない。2. Description of the Related Art Conventionally, a KB disk method has been known as a standard method for measuring drug sensitivity to bacteria, cells, and the like. The KB disk method is a method for visually determining the extent to which the growth of bacteria and cells is suppressed around a filter paper to which a drug has been added in advance. Therefore, it is necessary to grow bacteria and cells to such an extent that they can be visually judged, and there is an inconvenience that the required time becomes extremely long. In particular, such as rapid administration of antibiotics and intraoperative administration of anticancer drugs,
If the drug sensitivity needs to be measured quickly, it cannot be dealt with at all.
【0003】このような不都合を解消するために、薬剤
を添加した液体培地に細菌、細胞などを植え付け、呼吸
活性(=酸素消費量)を酸素電極を用いて測定し、細
菌、細胞などに対する薬剤感受性を測定する方法が提案
されている(特開昭56−140898号公報参照)。
この方法を採用すれば、薬剤感受性を迅速に測定するこ
とができると思われる。In order to solve such inconvenience, bacteria, cells, etc. are inoculated in a liquid medium containing a drug, and the respiratory activity (= oxygen consumption) is measured using an oxygen electrode. A method for measuring sensitivity has been proposed (see JP-A-56-140898).
If this method is adopted, it seems that drug sensitivity can be measured quickly.
【0004】[0004]
【発明が解決しようとする課題】しかし、特開昭56−
140898号公報に記載された方法は、単純に液体培
地中の溶存酸素量(溶存酸素濃度)を測定するのである
が、薬剤の濃度が著しく濃く、細菌、細胞などの活動を
完全に停止させない限り時間とともに溶存酸素量が減少
してゆくとともに、液体培地中の初期溶存酸素量が一定
ではないので、例えば、測定開始から一定時間が経過し
た時点で溶存酸素量を測定するようにしても、薬剤感受
性を正確に測定することは到底不可能である。However, Japanese Patent Application Laid-Open No.
The method described in Japanese Patent No. 140898 simply measures the amount of dissolved oxygen (dissolved oxygen concentration) in a liquid medium. However, unless the drug concentration is extremely high and the activities of bacteria, cells, etc. are completely stopped, As the dissolved oxygen amount decreases with time, and the initial dissolved oxygen amount in the liquid medium is not constant, for example, even if the dissolved oxygen amount is measured after a certain time has elapsed from the start of the measurement, It is almost impossible to accurately measure sensitivity.
【0005】[0005]
【発明の目的】この発明は上記の問題点に鑑みてなされ
たものであり、短時間で薬剤感受性などの生理活性を正
確に測定することができる生理活性測定方法およびその
装置を提供することを目的としている。SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned problems, and an object of the present invention is to provide a method and an apparatus for measuring a physiological activity which can accurately measure a physiological activity such as drug sensitivity in a short time. The purpose is.
【0006】[0006]
【課題を解決するための手段】請求項1の生理活性測定
方法は、生理活性測定対象物質を添加した培地と、生理
活性測定対象物質および生理活性測定用試薬を添加した
培地とを準備し、両培地中の溶存酸素量を酸素電極を用
いて測定し、測定された溶存酸素量を比較することによ
り生理活性を測定するに当って、酸素電極に対して測定
のためのバイアス電圧を印加した後、第1の所定時間が
経過してから第2の所定時間が経過するまでの時間範囲
内における溶存酸素量の変化割合に基づいて生理活性を
測定する方法である。According to a first aspect of the present invention, there is provided a method for measuring a physiological activity, comprising preparing a medium containing a substance to be measured and a medium containing a substance to be measured and a reagent for measuring a physiological activity. The amount of dissolved oxygen in both media was measured using an oxygen electrode, and in measuring the physiological activity by comparing the measured amount of dissolved oxygen, a bias voltage for measurement was applied to the oxygen electrode. Thereafter, a physiological activity is measured based on a change rate of a dissolved oxygen amount within a time range from when a first predetermined time elapses to when a second predetermined time elapses.
【0007】請求項2の生理活性測定方法は、第1の所
定時間として、酸素電極に対して測定のためのバイアス
電圧を印加した後、溶存酸素量に依存しない過渡的な電
流の割合が第1の所定割合以下になるまでの時間を採用
し、第2の所定時間として、培地中の溶存酸素量が当初
の溶存酸素量に対して第2の所定割合以下になるまでの
時間又は一定時間を採用する方法である。According to a second aspect of the present invention, after a bias voltage for measurement is applied to the oxygen electrode as the first predetermined time, the ratio of the transient current which does not depend on the amount of dissolved oxygen is changed. The time until the amount of dissolved oxygen in the medium becomes equal to or less than the second predetermined ratio with respect to the amount of dissolved oxygen in the medium is used as the second predetermined time. It is a method of adopting.
【0008】請求項3の生理活性測定装置は、生理活性
測定対象物質を添加した培地と、生理活性測定対象物質
および生理活性測定用試薬を添加した培地と、両培地中
の溶存酸素量を測定する酸素電極と、測定された溶存酸
素量を比較することにより生理活性を出力する生理活性
測定結果出力手段とを含み、生理活性測定結果出力手段
として、酸素電極に対して測定のためのバイアス電圧を
印加した後、第1の所定時間が経過してから第2の所定
時間が経過するまでの時間範囲内における溶存酸素量の
変化割合に基づいて生理活性を測定し、出力するものを
採用している。The physiological activity measuring apparatus according to claim 3 measures the amount of dissolved oxygen in both the medium containing the substance to be measured and the medium containing the substance to be measured and the reagent for measuring the physiological activity. An oxygen electrode, and a bioactivity measurement result output means for outputting a bioactivity by comparing the measured dissolved oxygen amount, as a bioactivity measurement result output means, a bias voltage for measurement with respect to the oxygen electrode Is applied, the physiological activity is measured based on the change rate of the dissolved oxygen amount within the time range from when the first predetermined time elapses to when the second predetermined time elapses, and an output is used. ing.
【0009】請求項4の生理活性測定装置は、第1の所
定時間として、酸素電極に対して測定のためのバイアス
電圧を印加した後、溶存酸素量に依存しない過渡的な電
流の割合が所定割合以下になるまでの時間を採用し、第
2の所定時間として、培地中の溶存酸素量が当初の溶存
酸素量に対して所定割合以下になるまでの時間を採用す
るものである。According to a fourth aspect of the present invention, after applying a bias voltage for measurement to the oxygen electrode as the first predetermined time, the ratio of the transient current which does not depend on the dissolved oxygen amount is determined. The time until the ratio becomes equal to or less than the ratio is adopted, and as the second predetermined time, the time until the dissolved oxygen amount in the medium becomes equal to or less than the predetermined ratio with respect to the initial dissolved oxygen amount is adopted.
【0010】[0010]
【作用】請求項1の生理活性測定方法であれば、生理活
性測定対象物質を添加した培地と、生理活性測定対象物
質および生理活性測定用試薬を添加した培地とを準備
し、両培地中の溶存酸素量を酸素電極を用いて測定し、
測定された溶存酸素量を比較することにより生理活性を
測定するに当って、酸素電極に対して測定のためのバイ
アス電圧を印加した後、第1の所定時間が経過してから
第2の所定時間が経過するまでの時間範囲内における溶
存酸素量の変化割合に基づいて生理活性を測定するので
あるから、両培地中の溶存酸素量の変化割合に有意な差
が有るか否かに基づいて生理活性を測定することができ
る。また、所要時間に関しては、第1の所定時間が経過
してから第2の所定時間が経過するまでの時間範囲内に
おける溶存酸素量の変化割合を測定すればよいのである
から、KBディスク法と比較して所要時間を著しく短縮
することができる。さらに、生理活性測定の正確さに関
しては、溶存酸素量の変化割合を用いるとともに、両培
地中の溶存酸素量の変化割合に有意な差が有るか否かを
判定するようにしているのであるから、特開昭56−1
40898号公報に記載された方法と比較して正確さを
著しく高めることができる。According to the method of the first aspect, a medium containing a substance to be measured and a medium containing a substance to be measured and a reagent for measuring a physiological activity are prepared. Measure the amount of dissolved oxygen using an oxygen electrode,
In measuring the physiological activity by comparing the measured dissolved oxygen amounts, after applying a bias voltage for measurement to the oxygen electrode, a second predetermined time has passed after a first predetermined time has elapsed. Since the physiological activity is measured based on the change rate of the dissolved oxygen amount in the time range until the time elapses, based on whether there is a significant difference in the change rate of the dissolved oxygen amount in both culture media. Physiological activity can be measured. As for the required time, the change rate of the amount of dissolved oxygen in the time range from when the first predetermined time elapses to when the second predetermined time elapses may be measured. In comparison, the required time can be significantly reduced. Furthermore, regarding the accuracy of the physiological activity measurement, the change rate of the dissolved oxygen amount is used, and it is determined whether or not there is a significant difference in the change rate of the dissolved oxygen amount in both culture media. JP-A-56-1
The accuracy can be significantly increased as compared to the method described in US Pat.
【0011】請求項2の生理活性測定方法であれば、第
1の所定時間として、酸素電極に対して測定のためのバ
イアス電圧を印加した後、溶存酸素量に依存しない過渡
的な電流の割合が第1の所定割合以下になるまでの時間
を採用し、第2の所定時間として、培地中の溶存酸素量
が当初の溶存酸素量に対して第2の所定割合以下になる
までの時間又は一定時間を採用するのであるから、請求
項1と同様の作用を達成することができる。According to the physiological activity measuring method of the present invention, after applying a bias voltage for measurement to the oxygen electrode as the first predetermined time, the ratio of the transient current not depending on the dissolved oxygen amount is determined. Adopts the time until the amount becomes less than or equal to the first predetermined ratio, and as the second predetermined time, the time until the amount of dissolved oxygen in the medium becomes equal to or less than the second predetermined ratio with respect to the initial amount of dissolved oxygen or Since the fixed time is employed, the same operation as the first aspect can be achieved.
【0012】請求項3の生理活性測定装置であれば、生
理活性測定対象物質を添加した培地と、生理活性測定対
象物質および生理活性測定用試薬を添加した培地とを準
備し、両培地中の溶存酸素量を酸素電極により測定し、
測定された溶存酸素量を生理活性測定結果出力手段によ
って比較することにより生理活性を出力するに当って、
生理活性測定結果出力手段において、酸素電極に対して
測定のためのバイアス電圧を印加した後、第1の所定時
間が経過してから第2の所定時間が経過するまでの時間
範囲内における溶存酸素量の変化割合に基づいて生理活
性を測定し、出力することができる。したがって、両培
地中の溶存酸素量の変化割合に有意な差が有るか否かに
基づいて生理活性を測定することができる。また、所要
時間に関しては、第1の所定時間が経過してから第2の
所定時間が経過するまでの時間範囲内における溶存酸素
量の変化割合を測定すればよいのであるから、KBディ
スク法と比較して所要時間を著しく短縮することができ
る。さらに、生理活性測定の正確さに関しては、溶存酸
素量の変化割合を用いるとともに、両培地中の溶存酸素
量の変化割合に有意な差が有るか否かを判定するように
しているのであるから、特開昭56−140898号公
報に記載された方法と比較して正確さを著しく高めるこ
とができる。According to the third aspect of the present invention, a medium to which a substance to be measured for physiological activity is added and a medium to which a substance to be measured and a reagent for measuring physiological activity are added are prepared. Measure the amount of dissolved oxygen with an oxygen electrode,
In outputting the physiological activity by comparing the measured dissolved oxygen amount by the physiological activity measurement result output means,
In the physiological activity measurement result output means, after applying a bias voltage for measurement to the oxygen electrode, the dissolved oxygen within a time range from when a first predetermined time elapses to when a second predetermined time elapses. The physiological activity can be measured and output based on the rate of change of the amount. Therefore, the physiological activity can be measured based on whether or not there is a significant difference in the rate of change in the amount of dissolved oxygen in both media. As for the required time, the change rate of the amount of dissolved oxygen in the time range from when the first predetermined time elapses to when the second predetermined time elapses may be measured. In comparison, the required time can be significantly reduced. Furthermore, regarding the accuracy of the physiological activity measurement, the change rate of the dissolved oxygen amount is used, and it is determined whether or not there is a significant difference in the change rate of the dissolved oxygen amount in both culture media. The accuracy can be significantly improved as compared with the method described in JP-A-56-140898.
【0013】請求項4の生理活性測定装置であれば、第
1の所定時間として、酸素電極に対して測定のためのバ
イアス電圧を印加した後、溶存酸素量に依存しない過渡
的な電流の割合が所定割合以下になるまでの時間を採用
し、第2の所定時間として、培地中の溶存酸素量が当初
の溶存酸素量に対して所定割合以下になるまでの時間を
採用するのであるから、請求項3と同様の作用を達成す
ることができる。According to the physiological activity measuring device of the present invention, after applying a bias voltage for measurement to the oxygen electrode as the first predetermined time, the ratio of the transient current which does not depend on the amount of dissolved oxygen. Since the time until the amount becomes equal to or less than the predetermined ratio is adopted, and as the second predetermined time, the time until the amount of dissolved oxygen in the medium becomes equal to or less than the predetermined ratio with respect to the initial amount of dissolved oxygen is adopted, The same operation as the third aspect can be achieved.
【0014】[0014]
【発明の実施の態様】以下、添付図面を参照しながらこ
の発明の実施の態様を詳細に説明する。図1はこの発明
の生理活性測定装置の一実施態様を概略的に示すブロッ
ク図、図2は酸素電極の構成および装着状態の一例を示
す概略図である。なお、この実施態様は、細菌の生理活
性のうち、薬剤感受性を測定するためのものである。Embodiments of the present invention will be described below in detail with reference to the accompanying drawings. FIG. 1 is a block diagram schematically showing one embodiment of the physiological activity measuring device of the present invention, and FIG. 2 is a schematic diagram showing an example of a configuration and an attached state of an oxygen electrode. This embodiment is for measuring drug sensitivity among the physiological activities of bacteria.
【0015】この実施態様においては、液体培地(例え
ば、従来公知の液体培地)のみを収容した第1測定セル
1と、液体培地および細菌を収容した第2測定セル2
と、液体培地、細菌および薬剤を収容した第3測定セル
3とを予め準備し、各セルにそれぞれ酸素電極4を設け
ている。この酸素電極4は、例えば、セラミックス基板
40上に印刷焼成により作用極43、参照極42、対極
44を形成し、不要部分をレジスト41により覆って各
極の露出面積が所定面積になるようにしてある。そし
て、各極にそれぞれ電気的に接続された引き出し端子4
5、46、47を形成してある。ただし、参照極42を
省略した構成の酸素電極を採用してもよい。In this embodiment, a first measuring cell 1 containing only a liquid medium (for example, a conventionally known liquid medium) and a second measuring cell 2 containing a liquid medium and bacteria.
And a third measurement cell 3 containing a liquid medium, bacteria and a drug are prepared in advance, and an oxygen electrode 4 is provided for each cell. In the oxygen electrode 4, for example, a working electrode 43, a reference electrode 42, and a counter electrode 44 are formed on a ceramic substrate 40 by printing and baking, and unnecessary portions are covered with a resist 41 so that the exposed area of each electrode becomes a predetermined area. It is. And a lead terminal 4 electrically connected to each pole.
5, 46 and 47 are formed. However, an oxygen electrode having a configuration in which the reference electrode 42 is omitted may be employed.
【0016】また、第1、第2、第3測定セル1、2、
3にそれぞれ設けられた酸素電極4に対して、ポテンシ
ョスタット11、21、31によってバイアス電圧を印
加している。このバイアス電圧は、例えば、参照極42
に対して−0.45Vの電圧であり、このバイアス電圧
を作用極43に印加するようにしている。このようにバ
イアス電圧が作用極43に印加されている状態におい
て、作用極43から出力される電流(溶存酸素量に対応
する電流であり、以下測定電流と称する)を電流−電圧
変換器12、22、32によって電圧信号に変換し、電
流−電圧変換器12、22、32から出力される電圧信
号をA/D変換器51によってディジタル電圧信号に変
換し、データ処理装置(例えば、パソコン)52に供給
し、データ処理装置52において薬剤感受性の測定を行
う。The first, second, and third measuring cells 1, 2,
A bias voltage is applied to the oxygen electrodes 4 provided on the reference numeral 3 by potentiostats 11, 21, and 31, respectively. This bias voltage is, for example, the reference electrode 42
The bias voltage is applied to the working electrode 43. In the state where the bias voltage is applied to the working electrode 43 in this manner, the current output from the working electrode 43 (a current corresponding to the amount of dissolved oxygen, hereinafter referred to as a measurement current) is supplied to the current-voltage converter 12, The A / D converter 51 converts the voltage signal output from the current-voltage converters 12, 22, 32 into a digital voltage signal, and converts the voltage signal output from the current-voltage converters 12, 22, 32 into a digital voltage signal. And the data processing device 52 measures the drug sensitivity.
【0017】ただし、第1測定セル1を省略してもよ
い。上記の構成の生理活性測定装置の作用を、図3に示
す測定電流の経時変化および図4に示すフローチャート
を参照しながら詳細に説明する。ステップSP1において
各酸素電極4に対してバイアス電圧を印加することによ
り薬剤感受性の測定を開始し、ステップSP2において、
測定開始から第1の所定時間t1(図3参照)が経過し
たか否かを判定し、第1の所定時間t1が経過していな
いと判定された場合には再びステップSP2の判定を行
う。逆に、第1の所定時間t1が経過したと判定された
場合には、ステップSP3において、測定開始から第2の
所定時間t2(図3参照)が経過したか否かを判定し、
第2の所定時間t2が経過していないと判定された場合
にはステップSP4において、各酸素電極4からの測定電
流を電圧信号に変換し、かつディジタル電圧信号に変換
してデータ処理装置52に取り込み、再びステップSP3
の判定を行う。逆に、ステップSP3において第2の所定
時間t2が経過したと判定された場合には、ステップSP
5において、取り込んだディジタル電圧信号のうちか
ら、測定タイミングが所定時間(例えば、10分間)の
ずれになる2つずつのディジタル電圧信号を抽出し、ス
テップSP6において、2つずつのディジタル電圧信号の
差分を算出し、ステップSP7において、算出された全て
の差分の平均値(差分平均値)を算出し、ステップSP8
において、第1、第2、第3測定セル1、2、3に対応
する差分平均値を比較することにより薬剤感受性の有無
を判定し、そのまま一連の処理を終了する。However, the first measuring cell 1 may be omitted. The operation of the physiological activity measuring device having the above-described configuration will be described in detail with reference to the change over time of the measured current shown in FIG. 3 and the flowchart shown in FIG. In step SP1, the measurement of drug sensitivity is started by applying a bias voltage to each oxygen electrode 4. In step SP2,
It is determined whether a first predetermined time t1 (see FIG. 3) has elapsed since the start of the measurement. If it is determined that the first predetermined time t1 has not elapsed, the determination in step SP2 is performed again. Conversely, when it is determined that the first predetermined time t1 has elapsed, in step SP3, it is determined whether or not a second predetermined time t2 (see FIG. 3) has elapsed since the start of the measurement.
When it is determined that the second predetermined time t2 has not elapsed, in step SP4, the measured current from each oxygen electrode 4 is converted into a voltage signal and converted into a digital voltage signal, and the converted current signal is transmitted to the data processing device 52. Capture, again step SP3
Is determined. Conversely, if it is determined in step SP3 that the second predetermined time t2 has elapsed, the process proceeds to step SP3.
5, two digital voltage signals whose measurement timing is shifted by a predetermined time (for example, 10 minutes) are extracted from the taken digital voltage signals, and in step SP 6, the two digital voltage signals are extracted. The difference is calculated, and in step SP7, the average value (difference average value) of all the calculated differences is calculated.
In, the presence or absence of drug sensitivity is determined by comparing the difference average values corresponding to the first, second, and third measurement cells 1, 2, and 3, and a series of processing ends.
【0018】なお、第1の所定時間は、酸素電極4にバ
イアス電圧を印加した直後の過渡的な電流が支配的な状
態が解消される時間である。換言すれば、酸素電極4の
表面の電気二重層への充電電流および電極近傍での酸素
の定常的拡散層を形成するまでの酸素消費のための電流
が減少して、溶存酸素量に依存しない過渡的な電流の割
合が第1の所定割合(例えば、20〜25%)以下にな
るまでの時間(例えば、1〜30分であり、細菌の薬剤
感受性を測定する場合には、5〜15分)である。ただ
し、予め設定した所定電流(例えば、経験的に定められ
る所定電流)よりも少なくなるまでの時間であってもよ
い。Note that the first predetermined time is a time during which a state in which a transient current is dominant immediately after a bias voltage is applied to the oxygen electrode 4 is eliminated. In other words, the charging current to the electric double layer on the surface of the oxygen electrode 4 and the current for oxygen consumption until the formation of a steady diffusion layer of oxygen near the electrode are reduced, and do not depend on the dissolved oxygen amount. Time (for example, 1 to 30 minutes) until the ratio of the transient current becomes equal to or less than the first predetermined ratio (for example, 20 to 25%), and 5 to 15 when measuring drug sensitivity of bacteria. Minute). However, a time until the current becomes smaller than a predetermined current (for example, a predetermined current empirically determined) may be used.
【0019】第2の所定時間は、酸素電極4の近傍で安
定な拡散層が形成され、溶液中の酸素濃度に比例した電
流が流れ、かつ溶液中の溶存酸素量が細菌の呼吸が不可
能なレベルにまで減少する時間である。換言すれば、溶
液中の溶存酸素量が当初の溶存酸素量に対して第2の所
定割合(例えば、50〜3%)以下になるまでの時間
(例えば、1分〜数日であり、細菌の薬剤感受性を測定
する場合には、数時間)である。ただし、溶液中の酸素
が細菌の呼吸により消費されて殆どなくなり、酸素濃度
減少速度が所定速度(例えば、ゼロに近い所定速度)よ
りも遅くなるまでの時間であってもよい。During the second predetermined time, a stable diffusion layer is formed in the vicinity of the oxygen electrode 4, a current proportional to the oxygen concentration in the solution flows, and the amount of dissolved oxygen in the solution makes it impossible for bacteria to breathe. It is time to decrease to a certain level. In other words, the time until the amount of dissolved oxygen in the solution becomes equal to or less than the second predetermined ratio (for example, 50 to 3%) with respect to the initial amount of dissolved oxygen (for example, one minute to several days, A few hours). However, the time until the oxygen in the solution is almost consumed by the respiration of the bacteria and almost disappears and the oxygen concentration decreasing speed becomes lower than a predetermined speed (for example, a predetermined speed close to zero) may be used.
【0020】第1、第2の所定時間は、溶液の量、電極
の面積、温度、溶液の粘度、溶液の組成(培地種)、電
極表面の粗度、細菌種とその濃度、溶液の空気との接触
面積、気圧、印加電圧、電極材料、薬剤の種類と濃度な
どの影響を受けるのであるから、これらの要因に基づい
て予め経験的に定めておくことが好ましい。図5は、細
菌としてE.coliを採用し、細菌濃度が10E8個
/ccのものと、細菌濃度が10E7個/ccのもの
と、細菌なしのものとを準備し、酸素電極から出力され
る測定電流値のみに基づく測定結果を示す図であり、細
菌濃度が10E8個/ccのものと細菌なしのものとを
識別することができるが、細菌濃度が10E7個/cc
のものと細菌なしのものとを識別することができないこ
とが分かる。The first and second predetermined times are the amount of the solution, the area of the electrode, the temperature, the viscosity of the solution, the composition of the solution (medium type), the roughness of the electrode surface, the bacterial species and their concentration, the air in the solution. It is affected by the contact area, pressure, applied voltage, electrode material, type and concentration of the drug, and the like. Therefore, it is preferable to determine in advance empirically based on these factors. FIG. 5 shows that E. coli as bacteria. E.coli, the bacteria concentration is 10E8 cells / cc, the bacteria concentration is 10E7 cells / cc, and the bacteria-free one are prepared, and the measurement result is based only on the measured current value output from the oxygen electrode. It is possible to discriminate between those having a bacterial concentration of 10E8 cells / cc and those having no bacteria, but having a bacterial concentration of 10E7 cells / cc.
It can be seen that it is not possible to distinguish between those without bacteria and those without bacteria.
【0021】これに対して図6は、細菌としてE.co
liを採用し、細菌濃度が10E7個/ccのものと、
細菌なしのものとを準備し、酸素電極から出力される測
定電流値の変化率(測定時刻が20分だけずれた時点に
おける測定電流値どうしの差分)に基づく測定結果を示
す図であり、細菌濃度が10E7個/ccのものと細菌
なしのものとを識別することができることが分かる。FIG. 6 shows E. coli as bacteria. co
li and a bacterial concentration of 10E7 / cc,
It is a diagram showing a measurement result based on the rate of change of the measured current value output from the oxygen electrode (the difference between the measured current values at the time when the measurement time is shifted by 20 minutes), prepared without the bacteria, It can be seen that the concentration of 10E7 cells / cc can be distinguished from that without bacteria.
【0022】なお、何れの図においても、0が細菌なし
のものを、7が細菌濃度が10E7個/ccのものを、
8が細菌濃度が10E8個/ccのものをそれぞれ示し
ている。また、0、7、8に続く数は、酸素電極の識別
番号を示している。図5と図6とを比較すれば、測定電
流値の変化率に基づく測定を行うことにより、測定感度
を高め得ることが分かる。In each of the figures, 0 is a sample without bacteria, 7 is a sample with a bacterial concentration of 10E7 cells / cc,
Reference numeral 8 indicates a bacterial concentration of 10E8 cells / cc. The numbers following 0, 7, and 8 indicate the identification numbers of the oxygen electrodes. A comparison between FIG. 5 and FIG. 6 shows that measurement sensitivity can be increased by performing measurement based on the rate of change of the measured current value.
【0023】図7は薬剤としてIPM(イミペネム)を
採用し、IPMの濃度(mcg/ml)を異ならせた場
合における測定電流の計時変化を示す図であり、このま
までは薬剤感受性の有無を判定することができない。し
かし、図8に示すように、測定電流値の変化率の経時変
化を採用すれば、薬剤感受性の有無を簡単に、かつ確実
に判定することができる。FIG. 7 is a diagram showing the time-dependent change of the measured current when IPM (imipenem) is adopted as the drug and the concentration (mcg / ml) of IPM is changed. In this state, the presence or absence of drug sensitivity is determined. Can not do. However, as shown in FIG. 8, if the change with time of the change rate of the measured current value is employed, the presence or absence of drug sensitivity can be easily and reliably determined.
【0024】図9はがん細胞に対する1%エタノールの
毒性を測定するための測定電流の経時変化を示す図であ
り、図10は酸素電極から出力される測定電流値の変化
率(測定時刻が1分だけずれた時点における測定電流値
どうしの差分)の経時変化を示す図である。なお、両図
において、黒丸は培地のみを、黒三角は培地と1%エタ
ノールを、白丸は培地とがん細胞(myeloma
3.3E6/ml)を、白三角は培地とがん細胞(my
eloma 3.3E6/ml)と1%エタノールを、
それぞれ示している。FIG. 9 is a diagram showing the change over time of the measured current for measuring the toxicity of 1% ethanol to cancer cells, and FIG. 10 is the change rate of the measured current output from the oxygen electrode (measurement time is It is a figure which shows a temporal change of the difference (measurement value between measured current values) at the time point shifted by 1 minute. In both figures, the closed circles indicate the medium only, the closed triangles indicate the medium and 1% ethanol, and the open circles indicate the medium and the cancer cells (myeloma).
3.3E6 / ml), open triangles indicate medium and cancer cells (my
elloma 3.3E6 / ml) and 1% ethanol
Each is shown.
【0025】この場合には、測定電流の経時変化を採用
しても、測定電流値の変化率の経時変化を採用しても、
がん細胞に対する1%エタノールの毒性を判定すること
ができるように思われるが、初期の溶存酸素濃度によっ
ては、測定電流の経時変化を採用した場合には、がん細
胞に対する1%エタノールの毒性を判定することができ
ない可能性がある。しかし、測定電流値の変化率の経時
変化を採用すれば、初期の溶存酸素濃度に拘らずがん細
胞に対する1%エタノールの毒性を判定することができ
る。In this case, whether the change in the measured current with time or the change in the rate of change in the measured current value with time is used.
It seems that the toxicity of 1% ethanol to cancer cells can be determined, but depending on the initial dissolved oxygen concentration, the toxicity of 1% ethanol to cancer cells can be determined by using the time course of the measured current. May not be determined. However, if the time-dependent change in the rate of change of the measured current value is employed, the toxicity of 1% ethanol on cancer cells can be determined regardless of the initial dissolved oxygen concentration.
【0026】また、図1、図2に示す実施態様におい
て、第3測定セル3の数を増加させ、それぞれの第3測
定セル3に濃度を異ならせた薬剤を添加しておくことに
より、薬剤感受性の有無のみならず、治療効果を期待で
きる薬剤の濃度をも測定することができる。以上から明
らかなように、測定所要時間を1時間以下にできるの
で、抗生物質の迅速投与、抗がん剤の手術中投与などの
用途に好適に適用することができる。In the embodiment shown in FIGS. 1 and 2, the number of the third measuring cells 3 is increased, and a drug having a different concentration is added to each of the third measuring cells 3 so that the number of the third measuring cells 3 is increased. Not only the presence or absence of sensitivity but also the concentration of a drug that can be expected to have a therapeutic effect can be measured. As is clear from the above, the time required for measurement can be reduced to 1 hour or less, so that it can be suitably applied to uses such as rapid administration of antibiotics and intraoperative administration of anticancer agents.
【0027】さらに、動物実験の代替、BODの測定、
環境指標生物の呼吸量の測定、血管障害の検出、DN
A、アレルギーの検出などに適用することが可能であ
る。DNAの検出を行う場合には、次の(1)〜(6)
の処理を行えばよい。 (1)酸素電極を金属表面加工剤(例えば、N−ヒドロ
キシサクシニマイド)で修飾する。Further, alternative to animal experiments, measurement of BOD,
Environmental indicators Measurement of organism respiration, detection of vascular disorders, DN
A. It can be applied to the detection of allergy and the like. When detecting DNA, the following (1) to (6)
May be performed. (1) The oxygen electrode is modified with a metal surface treating agent (for example, N-hydroxysuccinimide).
【0028】(2)検出したいDNAと相補的なDNA
(プローブ)にリンカー(例えば、アミノリンカー2)
を付ける。 (3)(1)と(2)を付け、検出電極とする。 (4)検出電極にサンプルDNAを添加し、DNAハイ
ブリタイゼーションを行う。(2) DNA complementary to DNA to be detected
(Probe) with a linker (for example, amino linker 2)
Attached. (3) Add (1) and (2) to make a detection electrode. (4) The sample DNA is added to the detection electrode to perform DNA hybridization.
【0029】(5)未反応のサンプルDNAを除去し、
DNAの非特異吸着剤(例えば、ポリアミン、2価の金
属イオン)を作用させる。 (6)溶液中で酸素出力(溶存酸素量を示す出力)を測
定し、コントロール(サンプルDNAの影響を受けない
出力)と比較して、サンプルDNA量を算出する。(5) removing unreacted sample DNA;
A non-specific adsorbent for DNA (eg, polyamine, divalent metal ion) is allowed to act. (6) Measure the oxygen output (output indicating the amount of dissolved oxygen) in the solution, and compare with the control (output not affected by the sample DNA) to calculate the sample DNA amount.
【0030】アレルゲンの検出を行う場合には、次の
(1)〜(5)の処理を行えばよい。 (1)酸素電極を金属表面加工剤(例えば、N−ヒドロ
キシサクシニマイド)で修飾する。 (2)アレルゲンに対する抗体を電極表面に吸着させ、
検出電極とする。 (3)検出電極にサンプルアレルゲンを添加し、抗原抗
体反応を行う。When detecting an allergen, the following processes (1) to (5) may be performed. (1) The oxygen electrode is modified with a metal surface treating agent (for example, N-hydroxysuccinimide). (2) adsorb the antibody against the allergen on the electrode surface,
This is a detection electrode. (3) A sample allergen is added to the detection electrode, and an antigen-antibody reaction is performed.
【0031】(4)未反応のサンプルアレルゲンを除去
し、蛋白の非特異吸着剤(例えば、ポリアミン、2価の
金属イオン)を作用させる。 (5)溶液中で酸素出力(溶存酸素量を示す出力)を測
定し、コントロール(サンプルアレルゲンの影響を受け
ない出力)と比較して、サンプルアレルゲン量を算出す
る。(4) The unreacted sample allergen is removed, and a non-specific adsorbent for the protein (eg, polyamine, divalent metal ion) is allowed to act. (5) The oxygen output (output indicating the amount of dissolved oxygen) in the solution is measured and compared with the control (output not affected by the sample allergen) to calculate the sample allergen amount.
【0032】なお、アレルゲンの検出を行う方法を採用
して、他の蛋白(ケミカルメディエーターなど)を測定
することが可能である。さらに、細菌の薬剤感受性の測
定を行う方法と同様の方法を採用して、動物細胞(ヒト
癌細胞、動物実験代替)、BODを測定することが可能
である。さらにまた、一酸化窒素は酸素電極で直接測定
することができるので、血管障害の検出に適用すること
ができる。Incidentally, it is possible to measure other proteins (such as chemical mediators) by employing a method for detecting allergens. Furthermore, animal cells (human cancer cells, alternative to animal experiments) and BOD can be measured by employing the same method as that for measuring drug sensitivity of bacteria. Furthermore, since nitric oxide can be measured directly with an oxygen electrode, it can be applied to the detection of vascular disorders.
【0033】[0033]
【発明の効果】請求項1の発明は、両培地中の溶存酸素
量の変化割合に有意な差が有るか否かに基づいて生理活
性を測定することができ、しかも所要時間を著しく短縮
することができるとともに、正確さを著しく高めること
ができるという特有の効果を奏する。According to the first aspect of the present invention, the physiological activity can be measured based on whether or not there is a significant difference in the rate of change of the dissolved oxygen amount between the two media, and the required time is significantly reduced. And the specific effect that accuracy can be significantly increased.
【0034】請求項2の発明は、請求項1と同様の効果
を奏する。請求項3の発明は、両培地中の溶存酸素量の
変化割合に有意な差が有るか否かに基づいて生理活性を
測定することができ、しかも所要時間を著しく短縮する
ことができるとともに、正確さを著しく高めることがで
きるという特有の効果を奏する。The second aspect of the invention has the same effect as the first aspect. The invention of claim 3 can measure the physiological activity based on whether or not there is a significant difference in the rate of change of the dissolved oxygen amount in both culture media, and can significantly reduce the required time, This has a unique effect that accuracy can be significantly increased.
【0035】請求項4の発明は、請求項3と同様の効果
を奏する。The fourth aspect of the invention has the same effect as the third aspect.
【図1】この発明の生理活性測定装置の一実施態様を概
略的に示すブロック図である。FIG. 1 is a block diagram schematically showing one embodiment of a physiological activity measuring device of the present invention.
【図2】酸素電極の構成および装着状態の一例を示す概
略図である。FIG. 2 is a schematic diagram showing an example of a configuration and a mounted state of an oxygen electrode.
【図3】測定電流の経時変化を示す図である。FIG. 3 is a diagram showing a change with time of a measured current.
【図4】薬剤感受性測定処理を説明するフローチャート
である。FIG. 4 is a flowchart illustrating a drug sensitivity measurement process.
【図5】細菌としてE.coliを採用し、細菌濃度が
10E8個/ccのものと、細菌濃度が10E7個/c
cのものと、細菌なしのものとを準備し、酸素電極から
出力される測定電流値のみに基づく測定結果を示す図で
ある。FIG. 5. E. coli as bacteria. E. coli and a bacterial concentration of 10E8 / cc and a bacterial concentration of 10E7 / cc
FIG. 9C is a diagram showing a measurement result based on only a measured current value output from an oxygen electrode, prepared for a sample having a sample c and a sample having no bacteria.
【図6】細菌としてE.coliを採用し、細菌濃度が
10E7個/ccのものと、細菌なしのものとを準備
し、酸素電極から出力される測定電流値の変化率に基づ
く測定結果を示す図である。FIG. 6 shows E. coli as bacteria. FIG. 9 is a diagram showing a measurement result based on a change rate of a measurement current value output from an oxygen electrode, prepared by using E. coli and having a bacterial concentration of 10E7 cells / cc and a bacterial-free one.
【図7】薬剤としてIPMを採用し、IPMの濃度を異
ならせた場合における測定電流の計時変化を示す図であ
る。FIG. 7 is a diagram showing a time change of a measured current when IPM is adopted as a drug and the concentration of IPM is varied.
【図8】薬剤としてIPMを採用し、IPMの濃度を異
ならせた場合における測定電流の変化率の計時変化を示
す図である。FIG. 8 is a diagram showing a time-based change in the rate of change of the measured current when IPM is used as a drug and the concentration of IPM is varied.
【図9】がん細胞に対する1%エタノールの毒性を測定
するための測定電流の経時変化を示す図である。FIG. 9 is a diagram showing a change over time of a measured current for measuring toxicity of 1% ethanol on cancer cells.
【図10】酸素電極から出力される測定電流値の変化率
の経時変化を示す図である。FIG. 10 is a diagram showing a change with time of a change rate of a measured current value output from an oxygen electrode.
4 酸素電極 52 データ処理装置 4 Oxygen electrode 52 Data processing device
───────────────────────────────────────────────────── フロントページの続き (72)発明者 新井 潤一郎 茨城県つくば市御幸が丘3番地 ダイキン 工業株式会社内 ──────────────────────────────────────────────────続 き Continuing from the front page (72) Inventor Junichiro Arai 3 Miyukigaoka, Tsukuba, Ibaraki Pref. Daikin Industries, Ltd.
Claims (4)
と、生理活性測定対象物質および生理活性測定用試薬を
添加した培地とを準備し、両培地中の溶存酸素量を酸素
電極(4)を用いて測定し、測定された溶存酸素量を比
較することにより生理活性を測定する方法であって、 酸素電極(4)に対して測定のためのバイアス電圧を印
加した後、第1の所定時間が経過してから第2の所定時
間が経過するまでの時間範囲内における溶存酸素量の変
化割合に基づいて生理活性を測定することを特徴とする
生理活性測定方法。1. A medium to which a substance to be measured for physiological activity is added and a medium to which a substance to be measured for physiological activity and a reagent for measuring physiological activity are added are prepared. The amount of dissolved oxygen in both mediums is measured by an oxygen electrode (4). A method for measuring a physiological activity by comparing the amount of dissolved oxygen measured using the method, wherein a bias voltage for measurement is applied to an oxygen electrode (4) for a first predetermined time A physiological activity measuring method characterized in that a physiological activity is measured based on a change rate of a dissolved oxygen amount within a time range from when a predetermined time elapses to when a second predetermined time elapses.
して測定のためのバイアス電圧を印加した後、溶存酸素
量に依存しない過渡的な電流の割合が第1の所定割合以
下になるまでの時間であり、第2の所定時間は、培地中
の溶存酸素量が当初の溶存酸素量に対して第2の所定割
合以下になるまでの時間又は一定時間である請求項1に
記載の生理活性測定方法。2. A method according to claim 1, wherein after applying a bias voltage for measurement to the oxygen electrode, a ratio of a transient current not depending on a dissolved oxygen amount is equal to or less than the first predetermined ratio. The second predetermined time is a time or a fixed time until the dissolved oxygen amount in the medium becomes equal to or less than a second predetermined ratio with respect to the initial dissolved oxygen amount. The method for measuring physiological activity according to the above.
と、生理活性測定対象物質および生理活性測定用試薬を
添加した培地と、両培地中の溶存酸素量を測定する酸素
電極(4)と、測定された溶存酸素量を比較することに
より生理活性を出力する生理活性測定結果出力手段(5
2)とを含む装置であって、 生理活性測定結果出力手段(52)は、酸素電極(4)
に対して測定のためのバイアス電圧を印加した後、第1
の所定時間が経過してから第2の所定時間が経過するま
での時間範囲内における溶存酸素量の変化割合に基づい
て生理活性を測定し、出力するものであることを特徴と
する生理活性測定装置。3. A medium to which a substance to be measured for physiological activity is added, a medium to which a substance to be measured for physiological activity and a reagent for measuring physiological activity are added, and an oxygen electrode (4) for measuring the amount of dissolved oxygen in both the medium. A physiological activity measurement result output means (5) for outputting a physiological activity by comparing the measured dissolved oxygen amount.
2) wherein the physiological activity measurement result output means (52) comprises an oxygen electrode (4).
After applying a bias voltage for measurement to
A physiological activity is measured and output based on a change rate of a dissolved oxygen amount within a time range from when a predetermined time elapses to when a second predetermined time elapses. apparatus.
して測定のためのバイアス電圧を印加した後、溶存酸素
量に依存しない過渡的な電流の割合が所定割合以下にな
るまでの時間であり、第2の所定時間は、培地中の溶存
酸素量が当初の溶存酸素量に対して所定割合以下になる
までの時間である請求項3に記載の生理活性測定装置。4. The method according to claim 1, wherein a bias voltage for measurement is applied to the oxygen electrode (4) for a first predetermined time until the ratio of a transient current that does not depend on the amount of dissolved oxygen becomes equal to or lower than a predetermined ratio. The physiological activity measuring device according to claim 3, wherein the second predetermined time is a time until the dissolved oxygen amount in the medium becomes a predetermined ratio or less with respect to the initial dissolved oxygen amount.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP09263997A JP3240953B2 (en) | 1997-04-10 | 1997-04-10 | Physiological activity measuring method and device therefor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP09263997A JP3240953B2 (en) | 1997-04-10 | 1997-04-10 | Physiological activity measuring method and device therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10276796A true JPH10276796A (en) | 1998-10-20 |
| JP3240953B2 JP3240953B2 (en) | 2001-12-25 |
Family
ID=14060028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09263997A Expired - Fee Related JP3240953B2 (en) | 1997-04-10 | 1997-04-10 | Physiological activity measuring method and device therefor |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3240953B2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001252066A (en) * | 2000-03-14 | 2001-09-18 | Daikin Ind Ltd | Bacteria count measurement method and device |
| WO2006057253A1 (en) * | 2004-11-24 | 2006-06-01 | Daikin Industries, Ltd. | Microbe counting method and microbe counting device |
| JP2006177934A (en) * | 2004-11-24 | 2006-07-06 | Daikin Ind Ltd | Microbe count measuring method and microbe count measuring apparatus |
| JP2008086279A (en) * | 2006-10-04 | 2008-04-17 | Nissui Pharm Co Ltd | Drug sensitivity evaluation method and microorganism identification method |
| US7955493B2 (en) | 2004-08-02 | 2011-06-07 | Daikin Industries, Ltd. | Method of measuring the number of bacteria, device of measuring the number of bacteria and cell used in the device |
-
1997
- 1997-04-10 JP JP09263997A patent/JP3240953B2/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001252066A (en) * | 2000-03-14 | 2001-09-18 | Daikin Ind Ltd | Bacteria count measurement method and device |
| US7955493B2 (en) | 2004-08-02 | 2011-06-07 | Daikin Industries, Ltd. | Method of measuring the number of bacteria, device of measuring the number of bacteria and cell used in the device |
| WO2006057253A1 (en) * | 2004-11-24 | 2006-06-01 | Daikin Industries, Ltd. | Microbe counting method and microbe counting device |
| JP2006177934A (en) * | 2004-11-24 | 2006-07-06 | Daikin Ind Ltd | Microbe count measuring method and microbe count measuring apparatus |
| KR100857808B1 (en) | 2004-11-24 | 2008-09-09 | 다이킨 고교 가부시키가이샤 | Microbe counting method and microbe counting device |
| JP2008086279A (en) * | 2006-10-04 | 2008-04-17 | Nissui Pharm Co Ltd | Drug sensitivity evaluation method and microorganism identification method |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3240953B2 (en) | 2001-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI285263B (en) | Method, system and kit for determining the presence of a sample within an electrochemical cell, and measuring analyte concentration in a sample | |
| Pundir et al. | Creatinine sensors | |
| KR100712380B1 (en) | Sample detection to initiate timing of an electrochemical assay | |
| EP0540691B1 (en) | Method for analytically utilizing microfabricated sensors during wet-up | |
| JP3982133B2 (en) | Measuring device using biosensor and biosensor and dedicated standard solution used therefor | |
| EP2909606B1 (en) | Device and methods of using device for detection of aminoacidopathies | |
| TW200914820A (en) | System and methods for determination of analyte concentration using time resolved amperometry | |
| WO2004061444A1 (en) | Thin analyzing device | |
| Arya et al. | Electrochemical immunosensor for tumor necrosis factor-alpha detection in undiluted serum | |
| CN105190299B (en) | The method based on descriptor of electrochemical measurement analyte and the unit and system with reference to this method | |
| JP2011506964A (en) | Speed reading gate amperometry | |
| JP2002535666A (en) | Diagnostic tests for the determination of analytes in biological fluids | |
| Merola et al. | Simple and suitable immunosensor for β-lactam antibiotics analysis in real matrixes: Milk, serum, urine | |
| JP2016529515A5 (en) | ||
| JPWO2004040286A1 (en) | Quantitative method for automatically discriminating sample liquid type and standard solution for biosensor | |
| CN105247358B (en) | Method using the cycle tests electrochemical measurement analyte with pulsed DC blocks and unit and system with reference to it | |
| JP3240953B2 (en) | Physiological activity measuring method and device therefor | |
| US20200264133A1 (en) | Methods and devices for the separation, detection and measurement of molecules in liquid samples | |
| WO2019176339A1 (en) | Protective film material for biosensor probe | |
| JP6795188B2 (en) | Electrode for fucose detection | |
| JPS61294356A (en) | Biosensor | |
| Cook et al. | Antibody‐based electrodes for hormonal and neurotransmitter measurements in vivo | |
| ES2823199T3 (en) | Pulse amperometry with fast reading | |
| Yáñez-Sedeño et al. | Electroanalysis and food analysis | |
| CN120121693A (en) | Identification of thyroid hormones using reactive heterogeneous nanopores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081019 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081019 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091019 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091019 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101019 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111019 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111019 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121019 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121019 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131019 Year of fee payment: 12 |
|
| LAPS | Cancellation because of no payment of annual fees |